Sprix

Eye Pain, Inflammation, corneal refractive surgery + 20 more

Treatment

2 FDA approvals

20 Active Studies for Sprix

What is Sprix

Ketorolac

The Generic name of this drug

Treatment Summary

Ketorolac is a type of medication used to reduce pain by reducing inflammation. It is available in the form of an oral tablet, injectable, nasal spray, and ophthalmic solution. It can be used to treat a variety of painful conditions, including postoperative pain, arthritis, menstrual disorders, headaches, and back pain. In some cases, it can be used as an alternative to opioids such as morphine and meperidine for pain management.

Toradol

is the brand name

Sprix Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Toradol

Ketorolac

1991

316

Approved as Treatment by the FDA

Ketorolac, also called Toradol, is approved by the FDA for 2 uses like caudal epidural block therapy and induction of Nerve Block .

caudal epidural block therapy

Used to treat caudal epidural block therapy in combination with Bupivacaine

induction of Nerve Block

Used to treat induction of Nerve Block in combination with Bupivacaine

Effectiveness

How Sprix Affects Patients

Ketorolac is a type of non-selective painkiller that blocks two enzymes (COX-1 and COX-2). The COX-1 enzyme is always active and can be found in the platelets, stomach lining, and blood vessel walls. The COX-2 enzyme is only active when inflammation, pain, or fever is present. When COX-1 is blocked, it leads to an increased risk of bleeding and stomach ulcers. The desired effects of the drug like reducing inflammation and pain come from blocking the COX-2 enzyme. Taking ketorolac long-term can lead to serious

How Sprix works in the body

Ketorolac works to reduce pain and inflammation in the body by blocking pathways that produce prostaglandins. Prostaglandins are molecules involved in inflammation and pain, and ketorolac works by stopping the enzymes that create them. The drug is a mixture of two molecules, but the active ingredient is responsible for its pain-relieving and anti-inflammatory effects.

When to interrupt dosage

The measure of Sprix is contingent upon the identified condition, for instance Eye, Macular Edema, Cystoid and Pericarditis Acute. The quantity of dosage is contingent on the approach of delivery (e.g. Tablet - Oral or Ophthalmic) referenced in the table underneath.

Condition

Dosage

Administration

Macular Edema, Cystoid

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Cataract Surgery

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

induction of Local Anaesthesia

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Miosis disorder

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Seasonal Allergic Conjunctivitis

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Ocular Itching

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Eye Pain

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Intraocular Lens Replacement

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Macular Edema, Cystoid

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

postoperative ocular pain

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Pain

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

caudal epidural block therapy

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Macular Edema

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Acute Coryza

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Pupil

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

induction of Nerve Block

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Pericarditis Acute

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Inflammation

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

corneal refractive surgery

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Induced Hyperthermia

, 5.0 mg/mL, 4.5 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 10.0 mg, 15.75 mg, 4.0 mg/mL, 5.0 mg, 60.0 mg/mL, 0.5 %, 0.4 %, 0.45 %, 2.88 mg/mL, 0.4 mg/mL, 40.0 mg/mL, 3.0 mg/mL, 9.0 mg/mL, 50.0 mg/mL, 45.0 mg/mL, 0.5 mg/mL, 10.0 mg/mL

Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, , Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated, Tablet, film coated - Oral, Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution, Solution - Ophthalmic, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular, Solution - Intramuscular, Tablet, Intramuscular, Liquid, Infiltration; Intramuscular; Intravenous; Topical, Kit, Kit - Infiltration; Intramuscular; Intravenous; Topical, Injection, solution - Ophthalmic, Epidural; Infiltration; Intramuscular; Intravenous, Kit - Epidural; Infiltration; Intramuscular; Intravenous, Intraocular, Injection, solution - Intraocular, Epidural; Infiltration; Intramuscular; Intravenous; Topical, Topical, Spray, metered - Topical, Kit - Epidural; Infiltration; Intramuscular; Intravenous; Topical, Solution, concentrate, Solution, concentrate - Intraocular; Irrigation, Intraocular; Irrigation, Injection - Intramuscular, Tablet - Oral, Injection, solution - Intramuscular, Injection, solution, concentrate - Intraocular, Injection, solution, concentrate, Kit - Ophthalmic

Warnings

Sprix has twenty-eight contraindications, thus it should not be administered if any of the conditions outlined in the following table exist.

Sprix Contraindications

Condition

Risk Level

Notes

Heart failure

Do Not Combine

Hyperkalemia

Do Not Combine

Renal Insufficiency

Do Not Combine

Hemorrhagic Disorders

Do Not Combine

Kidney Failure

Do Not Combine

A History of Gastric or Duodenal Ulcers

Do Not Combine

Liver Diseases

Do Not Combine

Major Surgery

Do Not Combine

Pulse Frequency

Do Not Combine

Gastrointestinal Hemorrhage

Do Not Combine

Crohn's Disease

Do Not Combine

suspected cerebrovascular bleeding

Do Not Combine

active Gastrointestinal Bleeding

Do Not Combine

NSAID-Induced Asthma

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

incomplete hemostasis

Do Not Combine

Coronary Artery Bypass Grafting

Do Not Combine

Gastrointestinal Perforation

Do Not Combine

Pulse Frequency

Do Not Combine

Hemorrhage

Do Not Combine

Peptic Ulcer

Do Not Combine

Pulse Frequency

Do Not Combine

Labour

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Third trimester of pregnancy

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Ketorolac may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Ketorolac may interact with Pulse Frequency

There are 20 known major drug interactions with Sprix.

Common Sprix Drug Interactions

Drug Name

Risk Level

Description

Aceclofenac

Major

The risk or severity of adverse effects can be increased when Ketorolac is combined with Aceclofenac.

Acemetacin

Major

The risk or severity of adverse effects can be increased when Ketorolac is combined with Acemetacin.

Acetylsalicylic acid

Major

The risk or severity of adverse effects can be increased when Ketorolac is combined with Acetylsalicylic acid.

Alclofenac

Major

The risk or severity of adverse effects can be increased when Ketorolac is combined with Alclofenac.

Alminoprofen

Major

The risk or severity of adverse effects can be increased when Ketorolac is combined with Alminoprofen.

Sprix Toxicity & Overdose Risk

Taking ketorolac can lead to side effects such as abdominal pain, indigestion, nausea, headaches, and fatigue in up to 39% of patients. An overdose can cause symptoms such as nausea, vomiting, upper abdominal pain, gastrointestinal bleeding, fatigue, and drowsiness. More severe effects such as high blood pressure, kidney damage or failure, hypoventilation, or coma may also occur in rare cases. Pregnant women should avoid ketorolac after 30 weeks gestation since it increases the risk of fetal ductus arteriosus closure. Women who are trying to conceive are also advised not to take ket

image of a doctor in a lab doing drug, clinical research

Sprix Novel Uses: Which Conditions Have a Clinical Trial Featuring Sprix?

188 active trials are being conducted to analyze the potential of Sprix in providing relief from Macular Edema, Cystoid, acute, moderate Pain and for Intraocular Lens Replacement.

Condition

Clinical Trials

Trial Phases

Inflammation

57 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 3

Induced Hyperthermia

0 Actively Recruiting

caudal epidural block therapy

4 Actively Recruiting

Not Applicable, Phase 4, Phase 3, Phase 2

Intraocular Lens Replacement

0 Actively Recruiting

Acute Coryza

0 Actively Recruiting

Macular Edema, Cystoid

0 Actively Recruiting

induction of Nerve Block

0 Actively Recruiting

Pupil

0 Actively Recruiting

Local Anaesthesia therapy

0 Actively Recruiting

corneal refractive surgery

0 Actively Recruiting

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Eye Pain

1 Actively Recruiting

Phase 1

postoperative ocular pain

0 Actively Recruiting

Eye

0 Actively Recruiting

Ocular Itching

0 Actively Recruiting

Pericarditis Acute

1 Actively Recruiting

Phase 2, Phase 3

Miosis disorder

0 Actively Recruiting

Macular Edema, Cystoid

0 Actively Recruiting

Macular Edema

1 Actively Recruiting

Phase 1, Phase 2

Cataract Surgery

3 Actively Recruiting

Not Applicable

Sprix Reviews: What are patients saying about Sprix?

5

Patient Review

6/19/2020

Sprix for Acute Pain Following an Operation

Despite the burning sensation that comes with this spray, it's an amazing drug. Toradol is a true miracle worker.

5

Patient Review

5/30/2019

Sprix for Acute Pain Following an Operation

This medication, in conjunction with Percocet, was prescribed to me for managing pain after ankle surgery. I never had to fill the Percocet script because the nasal spray worked so well. My surgeon was amazed at how good I looked just three days post-op.

5

Patient Review

12/8/2020

Sprix for Severe Pain

I'm so glad that there are non-narcotic pain relievers available that actually work! The downside is that they're quite expensive and not always easy to fill at a pharmacy.

5

Patient Review

9/2/2020

Sprix for Severe Lower Back Pain from Kidney Stones

This drug has been a total game-changer for me. I'm now five years sober from opiates, and while it does still burn, the pain relief is well worth it!

4.7

Patient Review

8/7/2018

Sprix for Severe Pain

This drug is really effective at removing pain. I can't take it every day, but when I do use it, it takes away the pain much better than Norco does. The only downside is that inhaling it burns really badly.

4.7

Patient Review

6/15/2020

Sprix for Acute Pain Following an Operation

This provided great pain relief after my outpatient procedure. The nose pain was gone almost instantly. However, it tastes really bad, so make sure you don't inhale it!

3.7

Patient Review

3/26/2020

Sprix for Severe Pain

Sprix is effective in pain relief, but unfortunately leaves the inside of my nose feeling raw and painful. I'm still pretty pleased overall, though.

3.7

Patient Review

12/15/2020

Sprix for Severe Pain

I'm not sure why everyone is complaining about the spray burning so much. Maybe they're not doing it right? You're not supposed to sniff the spray up your nose after you use it; it's supposed to sit in your nostril. If you do that (the correct way) it only burns a little bit for a few seconds. The only problem I had was that it made me sneeze after and caused my nose to run, which probably decreased some of the effectiveness. I did get some pain relief from this though.

3.7

Patient Review

10/30/2020

Sprix for Severe Pain

Sprix was prescribed to me by my doctor and it did help with the pain, though you have to be careful as NSAIDS can lead to other medical conditions. I started getting headaches after taking this medication and was recently diagnosed with bleeding on my brain.

3.7

Patient Review

5/7/2021

Sprix for Severe Pain

Sprix is an amazing medication for menstrual cramps, as it is a strong analgesic. Even though it burns when sprayed (I follow the directions), it's worth it to me to avoid cramps all day.

1.7

Patient Review

2/19/2020

Sprix for Severe Pain

The burning sensation I felt was really intense, like I had just sprayed battery acid into my nose.

1.3

Patient Review

3/17/2020

Sprix for Severe Pain

The burning sensation wasn't too bad, but I became nauseous when the medication ran down my throat.

1

Patient Review

3/25/2019

Sprix for Acute Pain Following an Operation

Not only was this treatment ineffective, but it also caused a lot of pain when I swallowed it.

1

Patient Review

12/5/2018

Sprix for Severe Pain

This product didn't work for me at all. Not only did it not stop the pain, but it also caused a burning sensation in my nose and throat that lasted for about 30-40 minutes after each dose. I tried it a third time and ended up with a nosebleed. Overall, this was a very unpleasant experience and I'll be sticking to naproxen from now on.

1

Patient Review

1/6/2019

Sprix for Severe Pain

This was a terrible experience. The burning sensation was unbearable. I would never take this drug again.

1

Patient Review

8/16/2019

Sprix for Severe Pain

Unfortunately, this medication did not work at all for my rheumatoid arthritis pain. If anything, it made the pain in my testicles worse.

1

Patient Review

5/6/2019

Sprix for Severe Pain

Unfortunately, this medication didn't provide the relief I was hoping for. If anything, it made my symptoms worse. Will not be trying again.

1

Patient Review

3/15/2019

Sprix for Acute Pain Following an Operation

This medication created a burning sensation that was unbearable. Additionally, it gave me really bad allergies and made me feel lightheaded and out of it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about sprix

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does it take for SPRIX to work?

"Ketorolac nasal spray (Sprix) starts working to relieve pain in as little as 20 to 30 minutes for some people."

Answered by AI

What is SPRIX medication?

"SPRIX should be used for the short-term management (5 days or less) of moderate to moderately severe pain that requires an opioid level of analgesia."

Answered by AI

Does SPRIX make you drowsy?

"You may feel briefly uncomfortable if you use this medication. You may also feel nauseous, dizzy, or tired. If you feel any of these effects for an extended period of time, please tell your doctor."

Answered by AI

What is SPRIX used for?

"Sprix is a medication used to manage moderate to moderately severe pain for a maximum of 5 days. It is classified as an opioid medication."

Answered by AI

Clinical Trials for Sprix

Image of University of Oklahoma Health Campus in Oklahoma City, United States.

Disulfiram for Rheumatoid Arthritis

18 - 75
All Sexes
Oklahoma City, OK

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and systemic immune activation. Obesity is common among individuals with RA and is associated with increased disease activity, reduced treatment response, and worse functional outcomes. Inflammation in adipose tissue, driven in part by activation of the NLRP3 inflammasome and downstream gasdermin D (GSDMD)-mediated pathways, may contribute to systemic inflammation and RA disease severity. Disulfiram (DSF), an FDA-approved medication for alcohol use disorder, has recently been identified as an inhibitor of GSDMD-mediated inflammatory signaling and pyroptosis. Preclinical studies suggest that DSF reduces inflammasome activation, inflammatory cytokine release, and metabolic dysfunction. This study is a 12-week, randomized, double-blind, placebo-controlled pilot trial designed to evaluate the safety, tolerability, and preliminary efficacy of DSF in overweight and obese adults with active RA despite stable disease-modifying antirheumatic drug (DMARD) therapy. Participants will be randomized to receive either DSF (250 mg daily) or placebo. The primary objective is to assess safety and tolerability. Secondary and exploratory objectives include evaluating the effects of DSF on systemic inflammation, RA disease activity, metabolic parameters, and adipose tissue inflammasome activation. Findings from this study will inform the feasibility and design of larger clinical trials targeting GSDMD-mediated inflammation in RA.

Phase 2
Waitlist Available

University of Oklahoma Health Campus

Beatriz Y Hanaoka, MD, MSc

Image of University of California, Riverside in Riverside, United States.

Acetazolamide for Altitude Sickness

18 - 65
All Sexes
Riverside, CA

High altitude travel can lead to inflammation in the body and activation of innate immune cells. The investigators' prior research demonstrates that 1 to 3 days at 3800 m elevation leads to increased expression of genes in blood cells that code for proteins that signal cell damage (damage associated molecular patterns (DAMPs)), cell receptors involved in innate immune responses, as well as increases in monocyte and neutrophil cells which promote inflammation. This study will investigate the potential mechanisms underlying these effects using the drug Acetazolamide, a carbonic anhydrase inhibitor which is known to reduce symptoms of Acute Mountain Sickness.

Phase < 1
Waitlist Available

University of California, Riverside

Image of Brigham and women's hospital in Boston, United States.

Corticosteroids for Heart Failure

18 - 80
All Sexes
Boston, MA

This pilot study investigates whether giving a short course of intravenous corticosteroids (methylprednisolone) alongside standard medical care can help patients recovering from heart failure-related cardiogenic shock. Heart failure-related cardiogenic shock happens when chronic heart dysfunction causes poor blood circulation and congestion throughout the body. Often, this condition triggers severe inflammation, making it harder for the heart and other organs to recover, even when temporary mechanical heart pumps are used to support blood flow. The study aims to see if reducing this inflammation with corticosteroids is safe and can help patients get better faster. Researchers will enroll 30 adult patients hospitalized with early-stage (SCAI Stage B or C) cardiogenic shock related to heart failure. To participate, patients must also show high levels of inflammation in their blood, specifically a high-sensitivity C-reactive protein (hsCRP) level of 20 mg/L or higher Participants will be randomly assigned by chance to one of two groups. One group will receive the standard of care alone. The other group will receive the standard of care plus a 7-day course of intravenous methylprednisolone. The main goal of the study is to measure the change in inflammation levels (hsCRP) over 7 days. Researchers will also monitor how well the patients' organs recover, track their need for blood pressure medications or mechanical heart pumps, and monitor for any side effects to ensure the treatment is safe

Phase 2
Waitlist Available

Brigham and women's hospital

Image of Exercise and Performance Nutrition Laboratory in Saint Charles, United States.

Multi-Strain Postbiotic for Inflammation and Gastrointestinal Symptoms

18 - 55
All Sexes
Saint Charles, MO

This study will evaluate the effects of a multi-strain postbiotic supplement on markers of inflammation, immune function, gastrointestinal symptoms, psychological well-being, and intestinal permeability in healthy adults. The primary objective is to determine whether four weeks of postbiotic supplementation alters physiological and perceptual responses to a standardized bout of moderate-to-high intensity exercise compared with placebo. Approximately 50 healthy men and women aged 18 to 55 years will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Participants will be randomly assigned to receive either a multi-strain postbiotic supplement or a matched placebo for 28 days. At the end of the supplementation period, participants will complete a 45-minute treadmill exercise bout at 75% of their individually determined maximum heart rate. Blood samples will be collected to assess biomarkers of inflammation, immune activity, and recovery. Gastrointestinal symptoms, intestinal permeability, anxiety, and perceived recovery will be evaluated using validated questionnaires. This study is designed to determine whether postbiotic supplementation modulates physiological stress responses and subjective well-being following prolonged exercise in healthy adults.

Waitlist Available
Paid Trial

Exercise and Performance Nutrition Laboratory

Chad M Kerksick, PhD

Have you considered Sprix clinical trials?

We made a collection of clinical trials featuring Sprix, we think they might fit your search criteria.
Go to Trials
Image of Byers Eye Institute in Palo Alto, United States.

LLM-Based Education for Cataract Surgery

18+
All Sexes
Palo Alto, CA

Patients with cataracts disease need to choose what type of artificial lens will go into their eye prior to surgery date. Some lenses are standard and are usually covered by insurance. Other "premium" lenses have various benefits such as reducing the need for glasses but usually require out-of-pocket costs. The combined busy outpatient clinic and complexity of artificial lens choices in the ever-changing world of cataract surgery tends to lead patients confused about their available lens options. There is an abundance of educational material present in premium lenses, however these are limited by accessibility and are standardized at single educational levels. Therefore in the present study, we want to test whether giving patients a short LLM powered AI-guided explanation from Custom GPT from OpenAI of lens options prior to their consultation with their doctor can improve visit efficiency, physician explanation and patient understanding of lens options. We will compare two groups: standard of care versus standard of care plus AI education. The LLM in this study is intended to provide supplemental information about premium intraocular lens(IOLs) options to study participants, and is no means supposed to replace a health care professional in the diagnosis, cure, treatment, and/or mitigation of disease. Study is analogous to giving a verified health pamphlet to a patient for them to view and learn different IOL options, in other words, facilitating patient understanding of their options. The LLM will be trained by several health care professionals and MD specialists to provide sufficient instructions. Sources will include verified online resources and MD information. The investigators hope to learn if a large language model-based educational tool can improve visit efficiency, physician explanation and patient understanding of intraocular lens options. New knowledge of this study could guide how cataract counseling is delivered in the future and may help clinics spend more time on individualized questions instead of repeating generic information.

Waitlist Available
Has No Placebo

Byers Eye Institute

Robert T Chang, MD

Image of University of New Brunswick in Fredericton, Canada.

Mediterranean Diet for Toddler Health

24 - 36
All Sexes
Fredericton, Canada

Toddlerhood (ages 2-3) is a critical window when the gut microbiome is still developing and eating habits are being established. Yet, many Canadian toddlers eat diets high in sugar and salt, which may affect long-term health. This study will test whether a MED diet can improve dietary inflammation, gut health, and body composition in toddlers and whether a tailored nutrition education program for parents can help families maintain healthy eating patterns. In this study, toddlers will be randomly assigned to a 3-week MED diet or their usual diet. Families in the MED diet group will receive free meal boxes for the 3 weeks, plus guidance from a nutrition researcher through a structured education program. The standard diet group will continue their regular diet with general nutrition advice. Researchers will collect dietary information, body composition assessments, and stool samples to measure gut microbiome composition and metabolites. This first study of a controlled diet intervention in toddlers, combining behavioral support, high-quality food provision, and advanced gut microbiome analysis, will help understand how early diet shapes lifelong eating habits and health, guiding public health strategies and precision nutrition approaches to prevent chronic disease from early life.

Waitlist Available
Has No Placebo

University of New Brunswick

Dr. Maryam Kebbe, PhD, CLC

Have you considered Sprix clinical trials?

We made a collection of clinical trials featuring Sprix, we think they might fit your search criteria.
Go to Trials
Image of University of California, San Francisco in San Francisco, United States.

Vision Centers for Eye Care

Any Age
All Sexes
San Francisco, CA

The goal of this clinical trial is to evaluate the effect of vision centers on access to eye care and eye health outcomes in South Asia. The main questions it aims to answer are: 1. Do vision centers increase visits to eyecare centers? 2. Do vision centers increase spectacle ownership and wearing? 3. Do vision centers improve visual acuity of the population? Researchers will compare outcomes in communities randomized to have a vision center is established with communities randomized to delay establishment of a vision center. Outcomes will be assessed through population-based surveys at baseline and after two years as well as through hospital records collected throughout the study period.

Waitlist Available
Has No Placebo

University of California, San Francisco

Kieran O'Brien, PhD, MPH

Image of UConn Health in Farmington, United States.

Cognitive Remediation for Memory and Thinking Difficulties

18+
All Sexes
Farmington, CT

The goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The main questions it aims to answer are: * Does computerized cognitive remediation improve cognitive performance and day-to-day functioning in older adults with postviral neurocognitive dysfunction? * Will treatment effects be maintained over time, leading to better long term cognitive outcomes? * Does the treatment lead to reductions in blood-based markers of inflammation as a potential mechanism of cognitive symptom improvement? * Can the treatment be optimized and refined based on feedback from participants to improve user (patient) experience? Researchers will compare the computerized cognitive remediation program to an active computer-based control condition (alternative computer activities) to see if the computerized cognitive remediation program works to treat postviral neurocognitive dysfunction. Participation takes approximately 43-48 hours over 7 months, with most activities (40-46 hours) completed within the first 7-8 weeks, including: * Initial intake visit: Eligibility confirmation (\~2-3 hours) * Computer activities: About 5 hours per week for \~6 weeks (total \~30 hours) completed on a computer tablet provided by the study and loaned to participants for use during the treatment phase * Weekly remote check-in meetings: \~30 minutes each during treatment * Blood draws: Two sessions (before and after treatment), \~20-30 minutes each * Three research visits: Pre-treatment, post-treatment, and 6-month follow-up (\~2-3 hours each, including assessments of cognitive, emotional, and daily functioning)

Recruiting
Has No Placebo

UConn Health

Cutter Lindbergh, Ph.D.

Have you considered Sprix clinical trials?

We made a collection of clinical trials featuring Sprix, we think they might fit your search criteria.
Go to Trials